Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

November

10

Exagen Inc. Reports Third Quarter 2021 Results

Quarterly Records: Ordering Healthcare Providers and Adopters SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...

4

electroCore Announces Third Quarter 2021 Financial Results

Third quarter 2021 revenue grew 17% sequentially and 38% over third quarter 2020 ROCKAWAY,...

4

ATEC Reports Third Quarter Financial Results and Recent Corporate Highlights

Total revenue growth of 53% including organic revenue growth of 29% Advancing adoption of...

27

Exagen Inc. Expands Coverage with Inland Empire Health Plan

Partnership to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus SAN...

25

Exagen Inc. Announces $27.2 Million Debt Refinancing

SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing...

20

electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England

Peer-reviewed paper appears in the British Journal of Healthcare Management ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE)...

14

electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine

Health Canada expands gammaCore label to include the acute and preventive treatment of migraine...

12

electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance

Third quarter 2021 revenue expected to be approximately $1.5 million; net cash used to fund operations...

6

TriSalus Life Sciences Appoints Sean Murphy to Board of Directors

Industry expert brings decades of experience commercializing biopharmaceutical, medical device and diagnostic products DENVER,...

29

ATEC Expands Platform with Launch of InVictus® OsseoScrew® Expandable Spinal Fixation

First and only commercially available expandable pedicle screw technology designed to optimize fixation and...

29

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1

Study evaluated impact of non-invasive vagus nerve stimulation in hospitalized COVID-19 patients ROCKAWAY, NJ, Sept....

29

Neurolens Names Mark Kremer Chief Revenue Officer

Coppell, Texas, September 29, 2021 – Following his announcement as CEO, Pierre Bertrand has simplified...

Recent developments

News

November

10

Exagen Inc. Reports Third Quarter 2021 Results

November

4

electroCore Announces Third Quarter 2021 Financial Results

November

4

ATEC Reports Third Quarter Financial Results and Recent Corporate Highlights

October

27

Exagen Inc. Expands Coverage with Inland Empire Health Plan

October

25

Exagen Inc. Announces $27.2 Million Debt Refinancing

October

20

electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England

October

14

electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine

October

12

electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance

October

6

TriSalus Life Sciences Appoints Sean Murphy to Board of Directors

September

29

ATEC Expands Platform with Launch of InVictus® OsseoScrew® Expandable Spinal Fixation

September

29

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1

September

29

Neurolens Names Mark Kremer Chief Revenue Officer